901. Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer.
Kim K, Kim MJ, Chung HH, Choi SC, Ryu SY, Kim JW, Park NH, Song YS, Kang SB.
Med Hypotheses. 2009 Dec;73(6):1005-7. Epub 2009 Jun 23.Link
900. Clinical impact of under-diagnosis by frozen section examination is minimal in borderline ovarian tumors.
Kim K, Chung HH, Kim JW, Park NH, Song YS, Kang SB.
Eur J Surg Oncol. 2009 Sep;35(9):969-73. Epub 2009 Mar 25.Link
899. Disease confined within the ovary and smaller amount of ascites are good prognostic factors for survival of patients with squamous cell carcinoma arising from mature cystic teratoma of the ovary: a case series in Korea and review of the published reports.
Kim HS, Kim JW, Chung HH, Park NH, Song YS, Kang SB.
898. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
Kim HS, Kim MK, Chung HH, Kim JW, Park NH, Song YS, Kang SB.
Gynecol Oncol. 2009 May;113(2):264-9. Epub 2009 Feb 8.Link
897. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
Kim HS, Kim JW, Cho JY, Chung HH, Park NH, Song YS, Kim SH, Kang SB.
Eur J Surg Oncol. 2009 Aug;35(8):870-6. Epub 2009 Jan 29.Link
896. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.